Jump to Content Jump to Main Navigation
User Account
  • Sign In to save searches and organize your favorite content.
  • Not registered? Sign up
  • My Content (0)

    Recently viewed (0)

    • Save Entry
  • Searches (0)

    Recently viewed (0)

    • Save Search
More
  • Subscriptions
  • Join E-mail List
  • Help
JNCCN
Menu
  • Home
  • Content
    • Current Issue
    • Past Issues
    • Featured Online Content
    • Supplements
    • NCCN Meeting Highlights
    • JNCCN In the News
  • COVID-19
  • CE
  • JNCCN 360
  • Author Center
    • Call for Papers
    • Submit a Manuscript
    • Information for Authors
    • Reprints/Permissions
  • About
    • JNCCN
    • Editorial Board
    • Editorial Calendar
    • NCCN
    • Harborside
Search
Close
Advanced Search Help

CURRENT ISSUE

June 2022 | Volume 20 | Issue 6

Current Issue
Past Issues
Featured Online Content

IN THIS ISSUE

NCCN Guidelines® Insights | CE

Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 3.2022

Original Research

Frailty in Patients With Newly Diagnosed Diffuse Large-B-Cell Lymphoma Receiving Curative-Intent Therapy: A Population-Based Study
 

Invited Commentary

The Last Word: Frailty and Diffuse Large B-Cell Lymphoma: Where Do We Go From Here?

FEATURED CONTENT

NCCN Guidelines®

Breast Cancer, Version 3.2022

Original Research

Is Biannual Surveillance for Pancreatic Cancer Sufficient in Individuals With Genetic Syndromes or Familial Pancreatic Cancer?

Original Research

Risk of New-Onset Prostate Cancer for Metformin Versus Sulfonylurea Use in Type 2 Diabetes Mellitus: A Propensity Score–Matched Study

Review | FEATURED ONLINE

Update on Guidelines for the Prevention of Cancer-Associated Thrombosis

Highlights of the NCCN 2022 Annual Conference

Updates to the Management of Patients With Relapsed or Refractory Indolent Follicular and Marginal Zone Lymphomas

Liver-Directed and Systemic Therapy Options for Hepatocellular Carcinoma

Updates in the Treatment of Multiple Myeloma

View More
 
JNCCN360

A collection of tumor-specific websites that cover oncology from every angle for the practicing clinician.

Acute Myeloid Leukemia
B-Cell Lymphomas
Biomarkers: NTRK Gene Fusions
Bladder Cancer
Breast Cancer
Chronic Lymphocytic Leukemia
Immunotherapy
Multiple Myeloma
Non-Melanoma Skin Cancers
Non–Small Cell Lung Cancer

 

 

Most Read

Chemotherapy-Induced Peripheral Neurotoxicity in Cancer Survivors: Predictors of Long-Term Patient Outcomes
NCCN Guidelines® Insights: Head and Neck Cancers, Version 1.2022
NCCN Guidelines® Updates: T-Cell Lymphomas
Getting Complex Therapies to More People: A Vexing Dilemma
Four-Year Disease-Free Remission in a Patient With POLE Mutation–Associated Colorectal Cancer Treated Using Anti–PD-1 Therapy

Most Cited

Prostate Cancer, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology
NCCN Guidelines Insights: Non–Small Cell Lung Cancer, Version 1.2020
Breast Cancer, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology
Esophageal and Esophagogastric Junction Cancers, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology
Head and Neck Cancers, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology

Tweets by JNCCN

Second Look: NCCN Guidelines Insights®

  • Multiple Myeloma, Version 3.2018

  • Colon Cancer, Version 2.2018

  • Head and Neck Cancers, Version 1.2018

  • Thyroid Carcinoma, Version 2.2018

  • Antiemesis, Version 2.2017

 

  • Advertising
  • Terms of Use
  • Privacy Policy
  • Contact Us
  • Permissions
  • Disclaimer

© 2019-2022 National Comprehensive Cancer Network

Follow us on: Share Share Share

Powered by:

PubFactory
  • [18.206.14.36]
  • 18.206.14.36